SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000929638-20-001063
Filing Date
2020-10-30
Accepted
2020-10-30 16:00:34
Documents
2
Group Members
BIHUA CHENCORMORANT GLOBAL HEALTHCARE GP, LLCCORMORANT GLOBAL HEALTHCARE MASTER FUND, LPCORMORANT PRIVATE HEALTHCARE FUND II, LPCORMORANT PRIVATE HEALTHCARE FUND III, LPCORMORANT PRIVATE HEALTHCARE GP II, LLCCORMORANT PRIVATE HEALTHCARE GP III, LLC

Document Format Files

Seq Description Document Type Size
1 schedule13g.htm SC 13G 132114
2 exhibit99-1.htm EX-99.1 6301
  Complete submission text file 0000929638-20-001063.txt   140396
Mailing Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET 52ND FLOOR BOSTON MA 02116 857-702-0388
Cormorant Asset Management, LP (Filed by) CIK: 0001583977 (see all company filings)

IRS No.: 462108927 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91774 | Film No.: 201277244
SIC: 2836 Biological Products, (No Diagnostic Substances)